pharmaphorum

AUGUST 10, 2021

Europe market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according to Andrew Obenshain, president of its severe genetic diseases unit. On the firm’s second-quarter results call, Obenshain said the biotech will start “an orderly wind-down” of its activities in Europe and seek “strategic alternatives” to make its therapies available to patients there

FDA 135

FDA 135

Outsourcing Pharma

AUGUST 9, 2021

Nanomeâs virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.

136

136

Fierce Healthcare

AUGUST 9, 2021

New survey finds COVID-19 is taking a significant toll on physicians. agliadkovskaya. Mon, 08/09/2021 - 15:51.

143

143

Pharma Marketing Network

AUGUST 11, 2021

Tune in with the Pharma Marketing Network for an insightful conversation with R.J. Lewis and Diane Bartoli, VP and General Manager of epocrates, as she shares her background with eCME, how COVID-19 has been driving it’s rapid growth, the other digital channels that have come into play, the term “snackable eCME” and how we can expect eCME to trend in a post-COVID sense.

97

97

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 10, 2021

Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma. It’s estimated that almost one in five people with asthma find it difficult to control symptoms using current therapies, while around 4% have particularly severe forms that puts them at risk of life-threatening attacks.

Hospitals 116

Hospitals 116

Outsourcing Pharma

AUGUST 10, 2021

The US-based company continues its move away from smoking products with the purchase of drug developer OtiTopic, as part of its Beyond Nicotine initiative.

115

115

Pharma Marketing Network

AUGUST 13, 2021

Sunny drives the promotion of global brands for pharmaceutical, biotech and medical. device. She founded Xavier Creative House (XCH), a healthcare marketing agency that. builds BOLD and EVOCATIVE designs, pushing the edge of creativity. Sunny is the point person for positioning your brand into a “Powerhouse.” As, CEO, she leads Operations and Client Management utilizing a wealth of experience gained from her roles in communications, compliance, and sales in rapid-growth companies.

Communication 52

Communication 52

pharmaphorum

AUGUST 10, 2021

BioNTech has suggested that giving booster doses of its current Comirnaty (BNT162b2) COVID-19 vaccine may be a preferable strategy to modifying the Pfizer-partnered shot. The comments came on the German biotech’s second-quarter results call, during which BioNTech raised its forecasts for revenues it will book from sales of the vaccine to €15.9 billion (almost $19 billion), on the back of contracts to deliver 2.2 billion doses this year with more than 1 billion already booked in for 2022.

Vaccines 116

Vaccines Immunization 116

Outsourcing Pharma

AUGUST 9, 2021

A leader from Longboat by Advarra outlines what it really means for a study to be patient centric, and how to succeed in achieving patient-centric trials.

111

111

Lifewell Rx Pharmacy

AUGUST 10, 2021

It may be difficult to keep track of your medications, especially if you are taking several at a time. However, it is important to stay on track with your medications, as missing a dose may affect your treatment and put you at risk of side effects. As a community pharmacy in Kentucky , we would like to help our customers manage their medications better to ensure their health and well-being.

Independent Pharmacies 52

Independent Pharmacies Community Pharmacies Dosage 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Med Ed 101

AUGUST 11, 2021

Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside of hospitals, (less than 48 hours from hospital admission). Patients will typically present with symptoms including fever, chills, chest pain, cough, sputum production, and dyspnea. Objective findings may include increased HR, respiratory rate >20 breaths/min, elevated WBC, crackles on auscultation, and evidence of consolidation (decreased breath […].

Hospitals 40

Hospitals 40

pharmaphorum

AUGUST 12, 2021

The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have been given the go-ahead. A report in The Times claims that the government is paying £22 a dose – up from an earlier price of £18 – for the Pfizer/BioNTech vaccine as part of a £1 billion deal for additional supplies, which is needed because existing stocks will be depleted next year.

Vaccines 111

Vaccines Immunization 111

Outsourcing Pharma

AUGUST 10, 2021

The University of Illinois at Chicago has been given $6m from the US Department of Defense to develop a potential treatment for severe cases of COVID-19.

111

111

Pharma Times

AUGUST 11, 2021

US biotech company says European payers have ‘not yet evolved their approach to gene therapy’

47

47

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Med Ed 101

AUGUST 8, 2021

Proton Pump Inhibitors (PPIs) are a well-known staple in the management of upper GI bleeds (UGIB). Recently, there was a question regarding the efficacy and appropriateness of PPI use in lower GI bleeds (LGIB). First, let’s evaluate some common characteristics used to differentiate between an UGIB and LGIB. Upper GI Bleed Hematemesis: vomiting both bright […].

40

40

pharmaphorum

AUGUST 12, 2021

With advertisers preparing to spend up to $15 billion on influencer marketing by 2022, pharmaceutical and biotech companies are increasingly (and carefully) engaging trusted health social influencers to connect more authentically with consumers. As pharma starts to leverage a multitude of high-engagement channels like influencer marketing, online communities and virtual health services, the industry finds itself in a unique position to reimagine traditional direct-to-consumer (DTC) efforts and p

Communication 111

Communication 111

Outsourcing Pharma

AUGUST 11, 2021

The US Food and Drug Administration has kept its staff busy with approvals, authorizations, and warnings related to various coronavirus-centered products.

FDA 98

FDA 98

Pharma Times

AUGUST 9, 2021

The enzyme replacement therapy is designed to target the key mannose-6-phosphate receptor pathway

49

49

pharmaphorum

AUGUST 11, 2021

Merck & Co is looking at a decision from the FDA in December on its application to market Keytruda as a post-surgery treatment for people with kidney cancer, after a priority review. The drugmaker – known as MSD outside the US and Canada – is seeking approval of Keytruda (pembrolizumab) as an adjuvant treatment for renal cell carcinoma (RCC) patients who have undergone surgery for the cancer and are at risk of relapse.

FDA 111

FDA 111

pharmaphorum

AUGUST 9, 2021

AstraZeneca’s Forxiga has become the first SGLT2 inhibitor to be approved in Europe for use in people with chronic kidney disease, extending its lead over rival drugs in the class. The European Commission has cleared Forxiga (dapagliflozin) for CKD in adults with or without diabetes, and the drug becomes the first new drug treatment for these patients in more than two decades.

FDA 111

FDA 111

pharmaphorum

AUGUST 13, 2021

Israeli femtech start-up GinaLife is developing a platform of biomarker strategies supported by artificial intelligence and data science for the early detection of problems in women’s health. CEO and co-founder Inbal Zafir-Lavie tells pharmaphorum more. Six years ago, research scientist Inbal Zafir-Lavie tragically lost her 38-year-old sister Hava Zafir to colorectal cancer.

105

105

pharmaphorum

AUGUST 9, 2021

Australian telecommunications giant Telstra has reached a deal to acquire MedicalDirector, a company specialising in software used by GPs to manage their practices. Telstra Health – the Australian group’s digital health arm – is paying A$350 million ($257 million) to buy MedicalDirector from investment company Affinity Equity Partners, which bought the company from former owner Healius for A$155 million in 2016.

Hospitals 105

Hospitals 105

pharmaphorum

AUGUST 12, 2021

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai’s new Alzheimer’s disease drug Aduhelm because it has not been shown to be medically effective. The company – said to be the largest health insurer in New York – said in a statement that Aduhelm (aducanumab) remains an investigational drug, even though it was approved by the FDA in June for Alzheimer’s, according to a media report.

Insurance 98

Insurance Department of Veterans Affairs FDA 98

pharmaphorum

AUGUST 11, 2021

South Korea’s SK Bioscience has been given the all-clear to start a phase 3 trial of its COVID-19 vaccine GBP510 that will compare the shot directly with AstraZeneca’s Vaxzevria. It is the first COVID-19 vaccine developed in South Korea to reach the pivotal trial stage, and from the earliest stages of its development has been earmarked as a possible candidate for rollout at scale across developing countries via the COVAX programme.

Vaccines 98

Vaccines Immunization 98

pharmaphorum

AUGUST 9, 2021

People across the world, especially the population aged 65 years or older, are suffering from some form of a medical condition that results in tooth decay or loss. According to statistics released by the Centers for Disease Control and Prevention, around 70.1% of the population in North America was 65 years or more and was suffering from a periodontal disease as well that resulted in loss of teeth.

Hospitals 98

Hospitals 98

pharmaphorum

AUGUST 9, 2021

Sanofi has added another string to its Pompe disease therapy bow, after getting FDA approval for Nexviazyme, its latest therapy for the rare, inherited disorder. The US regulator has approved Nexviazyme (avalglucosidase alfa) for the treatment of patients aged one year of age and older with late-onset Pompe disease , which progressively attacks the heart and skeletal muscles.

FDA 98

FDA Labelling 98

pharmaphorum

AUGUST 11, 2021

A jury in the US has charged a Florida man who owns multiple telemedicine companies in connection with a massive healthcare scam that involved a massive $784 million in fraudulent claims being submitted to Medicare. Creaghan Harry (53) is accused of conspiracy to commit health care fraud and wire fraud, and four counts of income tax evasion, activity which allowed him to live a “lavish lifestyle,” according to the Department of Justice, which said it is “one of the largest Med

93

93

pharmaphorum

AUGUST 12, 2021

Mahana Therapeutics has raised second-round financing of $61 million that will be used to launch what it says will be the first prescription digital therapeutics (DTx) for irritable bowel syndrome , one of several digital health products in its pipeline. The Mahana IBS tool – a three-month course that uses cognitive behavioural therapy (CBT) to log symptoms, and provide guidance on changing behaviour and thinking in a way that allows them to reduce the severity of IBS symptoms.

FDA 92

FDA 92

Outsourcing Pharma

AUGUST 12, 2021

The World Health Organizationâs Solidarity PLUS trial will kick off in 52 countries, trialing three drugs to treat patients hospitalized with COVID-19.

Hospitals 98

Hospitals 98

Outsourcing Pharma

AUGUST 10, 2021

The pharma firm is working with five US colleges and universities onto create programming designed to boost recruitment of Black talent in the industry.

93

93

pharmaphorum

AUGUST 9, 2021

Roche has the results it was hoping for in a phase 3 trial of Polivy in newly diagnosed diffuse large B-cell lymphoma (DLBCL) – an indication it thinks could be worth up to $2 billion. The Swiss drugmaker reported top-line results from the POLARIX study this morning, showing that Polivy (polatuzumab vedotin) was able to extend the time to disease progression or death when used alongside its Rituxan/MabThera antibody (rituximab) and chemotherapy as a first-line treatment for DLBCL, an aggressive

Chemotherapy 66

Chemotherapy 66

pharmaphorum

AUGUST 11, 2021

After rejecting Eli Lilly’s Verzenio for breast cancer therapy earlier this year, NICE has relented, recommending the drug for routine NHS use alongside hormonal therapy fulvestrant. A final appraisal document from the health technology assessment (HTA) agency backs the use of Verzenio (abemaciclib) alongside fulvestrant for the treatment of women with hormone receptor-positive, HER2-negative breast cancer in England and Wales.

Chemotherapy 64

Chemotherapy Documentation Hospitals 64

pharmaphorum

AUGUST 13, 2021

The FDA has cleared the use of third dose of either the Pfizer/BioNTech or Moderna COVID-19 vaccines for people with weakened immune systems, but stopped short of recommending a broader booster campaign. The emergency use authorisation (EUA) for the two mRNA-based vaccines has been amended so they can be used for solid organ transplant recipients or those with conditions that impair their immunity, who are at greater risk of severe disease. “Other individuals who are fully vaccinated are a

FDA 59

FDA Vaccines Immunization 59

Outsourcing Pharma

AUGUST 12, 2021

The Heart of Athletes study, using Deloitteâs ConvergeHealth MyPath for Clinical platform, aims to examine heart inflammation in athletes with the virus.

64

64